Trending NewsTrending NewsTop MarketRank™ StocksTop MarketRank™Top-Rated Dividend StocksTop-Rated DividendNYSE:CVS CVS Health (CVS) Stock Price, News & Analysis $83.76 +2.43 (+2.99%) Closing price 03:59 PM EasternExtended Trading$84.04 +0.28 (+0.34%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About CVS Health Stock (NYSE:CVS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CVS Health alerts:Sign Up Key Stats Today's Range$80.69▼$84.3850-Day Range$79.90▼$97.3652-Week Range$69.51▼$110.68Volume16.09 million shsAverage Volume8.55 million shsMarket Capitalization$107.12 billionP/E Ratio9.75Dividend Yield3.18%Price Target$108.25Consensus RatingModerate Buy Company Overview CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care. Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014. Its operations primarily serve customers and patients in the United States.AI Generated. May Contain Errors. Read More CVS Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks99th Percentile Overall ScoreCVS MarketRank™: 4.93071438181 of 5 starsCVS Health scored higher than 99% of companies evaluated by MarketBeat, and ranked 2nd out of 886 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingCVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on no strong buy ratings, 22 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialCVS Health has a consensus price target of $108.25, representing about 29.2% upside from its current price of $83.76.Amount of Analyst CoverageCVS Health has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about CVS Health's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth3.78% Earnings GrowthEarnings for CVS Health are expected to grow by 3.78% in the coming year, from $8.20 to $8.51 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CVS Health is 9.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.49.Price to Earnings Ratio vs. SectorThe P/E ratio of CVS Health is 9.75, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.97.Price to Earnings Growth RatioCVS Health has a PEG Ratio of 0.73. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCVS Health has a P/B Ratio of 1.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.28% of the float of CVS Health has been sold short.Short Interest Ratio / Days to CoverCVS Health has a short interest ratio ("days to cover") of 1.57, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CVS Health has recently decreased by 1.68%, indicating that investor sentiment is improving. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldCVS Health pays a meaningful dividend of 2.91%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCVS Health has only been increasing its dividend for 4 years.Dividend CoverageThe dividend payout ratio of CVS Health is 30.97%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, CVS Health will have a dividend payout ratio of 31.26% next year. This indicates that CVS Health will be able to sustain or increase its dividend.Read more about CVS Health's dividend. News and Social Media3.4 / 5News Sentiment0.41 News SentimentCVS Health has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 104 news articles for CVS Health this week, compared to 8 articles on an average week.Search Interest58 people have searched for CVS on MarketBeat in the last 30 days. This is an increase of 7% compared to the previous 30 days.MarketBeat Follows35 people have added CVS Health to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CVS Health insiders have not sold or bought any company stock.Percentage Held by Insiders0.85% of the stock of CVS Health is held by insiders.Percentage Held by Institutions80.66% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CVS Health's insider trading history. Receive CVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVS Stock News HeadlinesCVS will spin off Aetna after 8 years. What it means for Hartford16 minutes ago | msn.comCVS Health to split in two, separating pharmacy business from insuranceNovember 6 at 2:04 PM | msn.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 6 at 1:00 AM | Behind the Markets (Ad)CVS Health: The Breakup Puts A Price On The PharmacyNovember 6 at 2:04 PM | seekingalpha.comCVS and UnitedHealth lost ground on Medicare ratings. Who gained?November 6 at 2:04 PM | finance.yahoo.comElizabeth Warren Says CVS Is Still Trying To ‘Rip People Off’ With Planned Breakup as Mark Cuban Says Split ‘Changes Nothing For Patients’November 6 at 2:04 PM | finance.yahoo.comCVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?CVS Health beat Q3 earnings estimates and raised guidance, but shares fell 12% after it announced an unspecified 2028 split of its health services and pharmacy businesses, leaving analysts and investors awaiting more details.November 6 at 12:50 PM | marketbeat.comAlphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026 (CVS)Alphabet's 12% drop followed search and YouTube misses as Google Cloud beat. Altimetry likes Microsoft, AMD and Generac and avoids CoreWeave and Cipher Digital.November 2, 2026 | marketbeat.comSee More Headlines CVS Stock Analysis - Frequently Asked Questions How have CVS shares performed this year? CVS Health's stock was trading at $79.35 at the start of the year. Since then, CVS stock has increased by 5.6% and is now trading at $83.7580. How were CVS Health's earnings last quarter? CVS Health Corporation (NYSE:CVS) announced its quarterly earnings results on Wednesday, November, 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.65 by $0.44. The firm's revenue for the quarter was up 5.4% on a year-over-year basis. Read the conference call transcript. Does CVS Health have any subsidiaries? The following companies are subsidiaries of CVS Health: IlliniCare Health, EntrustRX, Aetna, TargetPharmacy, Omnicare, Navarro Discount Pharmacy, Coram Specialty Infusion, and more. Who are CVS Health's major shareholders? Top institutional investors of CVS Health include Pzena Investment Management LLC (0.81%), Assenagon Asset Management S.A. (0.35%), Sumitomo Mitsui Trust Group Inc. (0.22%) and Russell Investments Group Ltd. (0.19%). Insiders that own company stock include Larry Robbins, Prem S Shah, Michael F Mahoney, Anne A Finucane, Edward J Ludwig, Guy P Sansone, Guy P Sansone, Tilak Mandadi, James David Clark and Steven H Nelson. View institutional ownership trends. How do I buy shares of CVS Health? Shares of CVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CVS Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Health investors own include NVIDIA (NVDA), Pfizer (PFE), Johnson & Johnson (JNJ), Walt Disney (DIS), AT&T (T), Verizon Communications (VZ) and AbbVie (ABBV). Company Calendar Record date for 11/2 Dividend10/22/2026Ex-Dividend for 11/2 Dividend10/22/2026Dividend Payable11/02/2026Last Earnings11/04/2026Today11/06/20268th Annual Wolfe Research Healthcare Conference11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CVS's financial health is in the Red zone, according to TradeSmith. CVS has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:CVS CIK64803 Webwww.cvshealth.com Phone(401) 765-1500Fax401-762-2137Employees300,000Year Founded1963Price Target and Rating Average Price Target for CVS Health$108.25 High Price Target$123.00 Low Price Target$92.00 Potential Upside/Downside+29.2%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage25 Analysts Profitability EPS (Trailing Twelve Months)$8.59 Trailing P/E Ratio9.75 Forward P/E Ratio9.84 P/E Growth0.73Net Income$1.77 billion Net Margins2.62% Pretax Margin2.88% Return on Equity13.65% Return on Assets4.20% Debt Debt-to-Equity Ratio0.71 Current Ratio0.85 Quick Ratio0.66 Sales & Book Value Annual Sales$420.61 billion Price / Sales0.25 Cash Flow$15.60 per share Price / Cash Flow5.37 Book Value$63.09 per share Price / Book1.33Miscellaneous Outstanding Shares1,278,970,000Free Float1,268,099,000Market Cap$107.12 billion OptionableOptionable Beta0.58 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:CVS) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Health Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
